Skip to content

Author

Ning Cui

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer

A conceptual, hypothesis-generating framework is proposed in which ctDNA reports tumor-derived molecular signal and shedding, whereas immune assays report immune pressure and escape, which may, if prospectively validated, distinguish biologically different MRD states.

Ning Cui, H. Hao, Xiao-Feng Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.